GQ-1007

N/A

Report date: 2024/11/26 14:38:31
First In Class

Base Information

Drug NameGQ-1007
Drug Alias NameGQ-1007GQ1007
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionToll like receptor 7 agonistsToll like receptor 8 agonistsReceptor protein-tyrosine kinase erbB-2 modulators
TargetsToll like receptor 7Toll like receptor 8Receptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesGeneQuantum Healthcare (Suzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBrightgene Bio-Medical Technology Co LtdGeneQuantum Healthcare (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A